Hypoglycaemia during pregnancy in women with Type 1 diabetes

Diabetic Medicine - Tập 29 Số 5 - Trang 558-566 - 2012
Lene Ringholm1,2, Ulrik Pedersen‐Bjergaard3, Birger Thorsteinsson3,4, Peter Damm1,5,4, Elisabeth R. Mathiesen1,2,4
1Center for Pregnant Women with Diabetes, Rigshospitalet, University of Copenhagen
2Department of Endocrinology, Rigshospitalet, Copenhagen
3Endocrinology Section, Department of Cardiology, Nephrology and Endocrinology, Hillerød Hospital, Hillerød
4Faculty of Health Sciences, University of Copenhagen
5Department of Obstetrics, Rigshospitalet, Copenhagen, Denmark

Tóm tắt

Diabet. Med. 29, 558–566 (2012)

Abstract

Aims  To explore incidence, risk factors, possible pathophysiological factors and clinical management of hypoglycaemia during pregnancy in women with Type 1 diabetes.

Methods  Literature review.

Results  In women with Type 1 diabetes, severe hypoglycaemia occurs three to five times more frequently in early pregnancy than in the period prior to pregnancy, whereas in the third trimester the incidence of severe hypoglycaemia is lower than in the year preceding pregnancy. The frequency distribution of severe hypoglycaemia is much skewed, as 10% of the pregnant women account for 60% of all recorded events. Risk factors for severe hypoglycaemia during pregnancy include a history with severe hypoglycaemia in the year preceding pregnancy, impaired hypoglycaemia awareness, long duration of diabetes, low HbA1c in early pregnancy, fluctuating plasma glucose values (≤ 3.9 mmol/l or ≥ 10.0 mmol/l) and excessive use of supplementary insulin injections between meals. Pregnancy‐induced nausea and vomiting seem not to be contributing factors.

Conclusions  Striving for near‐normoglycaemia with focus on reduction of plasma glucose fluctuations during pregnancy should have high priority among clinicians with the persistent aim of improving pregnancy outcome among women with Type 1 diabetes. Pre‐conception counselling, carbohydrate counting, use of insulin analogues, continuous subcutaneous insulin infusion (insulin pump) therapy and real‐time continuous glucose monitoring with alarms for low glucose values might be relevant tools to obtain near‐normoglycaemia without episodes of severe hypoglycaemia.

Từ khóa


Tài liệu tham khảo

10.2337/diacare.26.11.2990

10.1136/bmj.315.7103.275

10.1016/j.jdiacomp.2007.03.008

10.1136/bmj.38043.583160.EE

10.2337/diacare.27.12.2819

10.1007/s00592-008-0024-0

10.2337/diacare.26.5.1385

10.1046/j.1471-0528.2003.02067.x

10.1111/j.1464-5491.1990.tb01405.x

10.2337/diab.46.2.271

10.2337/diacare.28.5.1245

10.1016/0029-7844(94)00415-A

10.2337/diacare.25.3.554

10.2337/dc07-1066

10.2337/diacare.15.8.1034

10.1002/dmrr.482

10.1111/j.1464-5491.2008.02495.x

10.2337/dc06-1887

10.1016/0002-9343(91)90605-W

10.1034/j.1600-0412.2000.079011958.x

10.1111/j.1464-5491.2010.03203.x

10.1002/dmrr.377

10.1016/0002-9378(92)91832-U

10.1016/0029-7844(95)00495-5

10.1002/dmrr.271

10.1111/j.1471-0528.1998.tb10180.x

10.1210/jc.2003-030282

10.1210/jc.2003-030726

10.1067/mob.2003.82

10.1152/ajpendo.1993.265.4.E572

Caufriez A, 1990, Placental growth hormone as a potential regulator of maternal IGF‐I during human pregnancy, Am J Physiol, 258, E1014

10.1007/BF00254298

10.1016/S0140-6736(00)04405-6

10.1007/s001250051530

10.2337/dc08-1832

10.1515/jpme.1987.15.1.83

10.1016/S0140-6736(98)07131-1

10.2337/diacare.26.2.274

10.1007/s00125-002-0969-4

10.1016/j.amjmed.2007.12.002

10.1111/j.1464-5491.2007.02263.x

10.3317/jraas.2008.001

10.1210/jc.75.3.906

10.1053/plac.2000.0535

10.1093/humrep/dei184

10.1210/jc.79.1.258

10.1016/j.diabres.2009.01.006

10.1016/j.jdiacomp.2009.07.006

10.1111/j.1464-5491.2009.02769.x

10.1111/j.1464-5491.1991.tb01575.x

10.2337/diacare.26.4.1106

10.2337/diacare.24.8.1501

An Advisory Board to the Driving Licence Committee of the European Union, 2006, Diabetes and Driving in Europe. A Report of the Second European Working Group on Diabetes and Driving

10.1172/JCI112622

10.1016/0002-9378(90)91213-V

10.1016/S0002-9378(96)70683-X

10.2337/dc08-1526

10.2337/dc07-1596

10.2337/diacare.23.7.905

10.2337/dc07-1225

10.1056/NEJM199109263251303

10.1111/j.1464-5491.2011.03300.x

10.1007/s00125-009-1633-z

10.2337/diacare.24.7.1130

10.1002/(SICI)1096-9136(199606)13:6<589::AID-DIA106>3.0.CO;2-P

10.2337/dc05-2265

10.1111/j.1464-5491.2004.01244.x

10.1111/j.1463-1326.2008.00976.x

10.1016/j.medcli.2010.11.021

10.2337/dc09-1605

10.1111/j.1464-5491.2007.02339.x

10.1016/j.clinthera.2008.08.013

10.1111/j.1464-5491.2009.02852.x

Mathiesen ER, 2011, Maternal Glycaemic Control and Hypoglycaemia in Pregnancy: a randomized trial comparing insulin detemir with NPH insulin in 310 subjects with type 1 diabetes, Diabetologia, 54, S486

10.1080/00016340701515282

10.2337/diacare.19.4.324

10.1136/bmj.d3805

10.1136/bmj.a1680

10.2337/dc07-0500

10.2337/dc10-1796

10.2337/dc06-1408

10.1089/dia.2010.0111

Coustan DR, 1986, A randomized clinical trial of the insulin pump vs intensive conventional therapy in diabetic pregnancies, J Am Med Assoc, 255, 631, 10.1001/jama.1986.03370050073024

10.1136/bmj.39505.641273.AD